Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Authors:
- Ehsan BitarafEBEhsan Bitaraf
- Seyyed Amir Yasin AhmadiSASeyyed Amir Yasin Ahmadi
- Alireza Gandomi-MohammadabadiAGAlireza Gandomi-Mohammadabadi
- Zahra Noorani MejarehZMZahra Noorani Mejareh
- Bahare AbdollahiBABahare Abdollahi
- Javad BalasiJBJavad Balasi
- Farzan MoodiFMFarzan Moodi
- Nima HemmatiNHNima Hemmati
- Ali KabirAKAli Kabir
Open Access
- 2 July 2021
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-21
Abstract
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death (Keywords
Funding Information
- Iran University of Medical Sciences (99-1-39-17694)
This publication has 28 references indexed in Scilit:
- Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysisClinical Microbiology and Infection, 2021
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19JAMA, 2020
- Successful use of methylprednisolone for treating severe COVID-19Journal of Allergy and Clinical Immunology, 2020
- Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019Polish Archives of Internal Medicine, 2020
- “Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- An Update on Current Therapeutic Drugs Treating COVID-19Current Pharmacology Reports, 2020
- Vitamin C for the treatment of COVID-19: A living systematic reviewmedRxiv, 2020
- Rational Use of Tocilizumab in the Treatment of Novel Coronavirus PneumoniaClinical Drug Investigation, 2020
- Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidenceecancermedicalscience, 2020
- Step away from stepwiseJournal of Big Data, 2018